Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors
Clinical trial NCT02345174 · COMPLETED
Trial details
- NCT number
- NCT02345174
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-19
- Primary completion
- 2016-06-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.